logo

Last Update

This profile was last updated on 7/31/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Ivan Horak?

Ivan D. Horak

President for Research and Development, Chief Scientitifc Officer

Enzon Pharmaceuticals , Inc.

HQ Phone:  (732) 980-4500

Direct Phone: (908) ***-****direct phone

Email: i***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Enzon Pharmaceuticals , Inc.

20 Commerce Drive Suite 135

Cranford, New Jersey,07016

United States

Company Description

Enzon Pharmaceuticals, Inc. is a biotechnology company that had been dedicated to the research and development of innovative therapeutics for patients with high unmet medical needs. Enzon receives royalty revenues on seven marketed products that utilize its pr...more

Background Information

Employment History

Chief Scientific and Medical Officer

Symphogen Inc


Chief Scientific Officer

Immunomedics , Inc.


CSO and Chief Marketing Officer

The Global Leaders


National Cancer Institute


Affiliations

American Society of Clinical Oncology

Member


American College of Physicians

Fellow


American Association for Cancer Research Inc

Member


American Society of Hematology

Member


Cancer Research

Member, Editorial Board


Biotechnology Industry Organization

Member of Advisory Board


Editorial

Board Member


All Conferences

Member of Advisory Board


GDS International Ltd

Delegate


American Association for Cancer Research Inc

Member, Various Committees


International Union

Member, Various Committees


Education

M.D. degree

University of Komenius


Web References(118 Total References)


Press Releases - Enzon

investor.enzon.com [cached]

Bridgewater, New Jersey, September 6, 2005 - Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced the appointment of Ivan Horak, M.D. to the position of Executive Vice President of Research and Development and Chief Scientific Officer.
In his new position Dr. Horak will oversee all aspects of Enzon's research and development, regulatory affa...


Executive Management - symphogen

www.symphogen.com [cached]

Ivan D. Horak, MD, FACP
Head of Global R&D, Chief Scientific and Medical Officer Prior to joining Symphogen in 2011, Dr. Horak served as President of Research and Development and Chief Scientific Officer of Enzon Pharmaceuticals Inc. Before that, Dr. Horak served as Chief Scientific Officer of Immunomedics, responsible for development of novel antibodies. Dr. Horak has authored over 80 peer-reviewed publications and several book chapters within the fields of hematol- ogy, oncology, and immunology and has served on the editorial boards of several scientific journals. Dr. Horak is a board-certified oncologist. He is a Fellow of the American College of Physicians and a member of the American Association for Cancer Research (AACR), the American Society of Hematology (ASH), and the American Society Clinical Oncology (ASCO).


Executive Management - symphogen

www.symphogen.com [cached]

Ivan D. Horak, MD, FACP
Head of Global R&D, Chief Scientific and Medical Officer Prior to joining Symphogen, Dr. Horak served as President of Research and Development and Chief Scientific Officer of Enzon Pharmaceuticals Inc. Before that, Dr. Horak served as Chief Scientific Officer of Immunomedics, responsible for development of novel antibodies. Dr. Horak has authored over 70 peer-reviewed publications and several book chapters within the fields of hematology, oncology, and immunology and has served on the editorial boards of several scientific journals. Dr. Horak is board certified oncologist. He is Fellow of American College of Physicians and member of American Association for Cancer Research, American Society of Hematology, and American Society Clinical Oncology.


execreps.com

64. Ivan D Horvak, Enzon Pharmaceuticals, Inc


cancer | Santaris

www.santarispharma.com [cached]

Dr. Ivan Horak
President of Research, Development and Chief Scientific Officer of Enzon Pharmaceuticals


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory